期刊名称：JOURNAL OF CHEMOTHERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
WHO ARE WE?
The Journal of Chemotherapy is an international scholarly journal published bimonthly in Florence, Italy and is published under the auspices of the Italian Society of Chemotherapy and of the Italian Federation of Human and Animal Mycopathology. The Journal of Chemotherapy deals with all aspects of antimicrobial, immunomodulating and anticancer chemotherapy.
The Journal of Chemotherapy is committed to the rapid publication of high quality, peer reviewed, original research and review articles, short communications and letters in English. Letters that comment on an article previously published in the Journal of Chemotherapy are also welcomed.
The Editorial team is committed to the highest standards in quality and peer review.
REASONS TO SUBSCRIBE:
· Expanded Editorial Board. The Editors have appointed some of the most prestigious researchers in the world to join the Journal of Chemotherapy.
· Online access. Subscribers to Journal of Chemotherapy can gain online access to article abstracts and tables of contents free of charge and to article full texts for a small fee.
REASONS TO SUBMIT YOUR
NEXT PAPER:
· Fast and high quality peer review.
· Rapid handling (with no submission or handling fees)
· Rapid publication (4-8 months after acceptance, depending on priority).
· Online publication ahead of print
· A journal increasingly recognised as an authoritative publication in the field
· Wide readership supported by online dissemination of contents via institutional access.
INTERNATIONAL INDEXES
AND DATABASES
The Journal of Chemotherapy is indexed in:
· Medline/Index Medicus
· Current Contents/Clinical Practice®
· Research Alert Direct®
· Chemical Abstracts
· EMBASE/Excerpta Medica
· BIOSIS
JOURNAL OF CHEMOTHERAPY ONLINE
website www.jchemother.it
Your benefits include:
· Online version of the Journal published weeks before the print version
· Online archive: full-text available which you can print
· Literature searches by author or keyword
· E-mail delivery of the latest tables of content
· Pay per view/Pay per admission services available
Instructions to Authors
1. The manuscript must be written in English and submitted electronically by e-mail to info@jchemother.it. The electronic copy must be spaced one and one-half, with numbered pages and lines. If the file is more than 5MB, send a compressed or zip file.
2. The author’s letter accompanying the manuscript must state that the manuscript has not been submitted for publication or previously published elsewhere. After publication the copyright of the article transfers to the Journal of Chemotherapy. Authors will be responsible for paying a page charge of € 30 per printed page after their article is accepted for publication. Members of the Journal of Chemotherapy Editorial Board, FIMUA and SIC will be charged a discounted page charge. When page proofs are sent to authors, we will enclose a pro-forma invoice which must be paid prior to publication of the paper.
3. Authors are responsible for obtaining permission from other copyright holders to reproduce any materials such as tables or figures which have already been published elsewhere. The copyrighted table or figure must contain in a footnote the source of the item and «with permission».
4. Experimental and clinical research papers, in most cases, should adhere to the following format: Title page, Summary, Introduction, Materials and Methods or Patients and Methods, Results, Discussion, Acknowledgements, References, Figure legends, Tables, Figures.
5. Reviews should always include a brief Summary and subsequent subheadings are at the author’s discretion.
6. Brief communications or Letters should not have a Summary, but be a brief explanation of the problem, methods, results and conclusion. No subheadings except Reference in the text. One or two tables and figures may be submitted with a Brief communication or Letter.
7. The title page must contain: (a) a concise but informative title; (b) names of all authors and their affiliating institutions indicated by numerical footnotes; (c) name, address, telephone, fax numbers and e-mail address of the author to whom correspondence is to be addressed.
8. The summary should be no more than 150 words. Provide 3-10 key words for indexing your article.
9. The introduction should state the background and purpose of the topic. Cite only those references which are strictly pertinent.
10. The materials and methods or patients and methods section should describe materials or your subjects as well as the methods sufficiently in detail to allow other researchers to reproduce your study.
11. Describe statistical methods with enough detail to allow reproduction of the study by another researcher.
12. The results which are presented in tabular or illustrative form should not be reiterated in the text, but only the most salient findings should be emphasized.
13. The discussion should relate the relevance of the study’s results to other data from the literature.
14. Grants or funding of the research from pharmaceutical firms must be stated in the Acknowledgements. Authors may also acknowledge institutional funding or grants as well as technical assistance and contributions not justifying authorship.
15. Use the Vancouver style reference system recommended by the International Committee of Medical Journal Editors. Number references consecutively in the order in which they are mentioned in the text. The numbers should be superscripts in the text and the reference list. Journal titles of more than one word are to be abbreviated according to the Index Medicus or PUBMED style. Journal titles of only one word should not be abbreviated at all. «Unpublished observations» and «personal communications » will not be accepted as references in the bibliography and should be inserted in the text in parentheses. The use of abstracts from meetings is discouraged.
See examples of correct forms of references below.
Journals (list all authors when six or less; when seven or more, list only first six and add “et al.”):
1 Low DE, Markovic MJ, Dowzicky MJ. Antimicrobial susceptibility among bacterial isolates from ICU and non-ICU settings and different age groups: results from the tigecycline evaluation and surveillance trial in North America. J Chemother 2009; 21 (1): 16-23.
2 Ito W, Takeda M, Jayaba H, Ueki S, Sato K, Honda K et al. Clinical evaluation after a notification policy of linezolid use: a case series of 22 patients. J Chemother 2009; 21 (1): 52-57.
Books and other monographs
3 Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press. 1995: Preface.
4 Barie PS. Management of complicated intraabdominal infections. In: Periti P, Tonelli F, eds. Proceedings of the Third Symposium on the Control of Surgical Infections. Florence, Italy. J Chemother 1999; 11 (6): 464-477.
5 The European Helicobacter pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997; 41: 8-13.
16. Tables should be numbered consecutively with Arabic numerals. Cite each table in the text. Obtain permission to reproduce data from another source (published or not). Give each table a brief title. Keep tables to a minimum.
17. Figures must be submitted in electronic format. Each figure must have a legand. Any photomicrographs must have an internal scale marker (do not give magnification because printing reduction will alter it). Cite all figures in text. If Authors want color reproduction of a figure, they will be charged for color printing. Contact the Managing Editor for a cost estimate. Keep figures to a minimum.
18. Drugs, chemicals and equipment should include the name of the manufacturer and city, inserted in parenthesis after the generic or international nonproprietary name.
19. Ethics: Any studies involving experimentation on human beings must indicate whether procedures were in accordance with the Helsinki Declaration or the Ethical Committee of the authors’ institution. Patients should not be identifiable in any photographs or their written permission is required. Authors are responsible for complying with national, international or institutional guidelines on the care and use of experimental animals.
20. Use the International System of Units (SI) for measurements, i.e., metric units, Celsius for temperatures. Follow SI abbreviations, for example, write microgram as µg, not mcg.
21. Use standard abbreviations. Avoid abbreviations in the title or summary. Aside from standard units of measurements, indicate the full term the first time an abbreviation is used in the text. Do not overuse abbreviations as they impede comprehension.
22. Provide the full Latin genus and species name (in italics) of all microorganisms the first time they are mentioned in the text and abbreviate genus name thereafter. For example, use Staphylococcus aureus the first time and S. aureus thereafter.
23. The first set of printer’s proofs will be sent to authors for correction and are corrected by the managing editor. Authors must return the corrected proofs to the managing editor within the time designated to insure that their corrections are inserted in the article. All papers are edited for English usage and for conformity to the journal’s bibliographic style. Authors must pay the page charges at the time of proof correction and prior to publication.
24. Authors will be sent a reprint price sheet and order form with the proofs. Reprints are available after publication of the article.
25. All articles are posted on the Journal of Chemotherapy website prior to print publication.
Editorial Board
Founding editor: Piero Periti
Editors: Teresita Mazzei
Enrico Mini
Andrea Novelli
Managing Editor: Mary Forrest
Advisory Board:Antimicrobial Agents
ADAM D. - München, Germany
AMICOSANTE G. - L’Aquila, Italy
AMYES S.G.B. - Edinburgh, UK
BANTAR C.E. - Paranà, Argentina
BARCHIESI F. - Ancona, Italy
BASSETTI M. - Genova, Italy
BAUERNFEIND A. - München, Germany
BLASI F. - Milano, Italy
BLONDEAU J. - Saskatoon, Canada
CASSONE A. - Roma, Italy
CASTAGNOLA E. - Genova, Italy
COLIZZA S. - Roma, Italy
CORNAGLIA G. - Verona, Italy
CUNHA B.A. - Mineola, NY, USA
DEBBIA E. - Genova, Italy
DE LALLA F - Vicenza, Italy
DE PAUW B.E. - Nijmegen, The Netherlands
DONELLI G. - Roma, Italy
ELKINS C.A. - Laurel, MD, USA
ELLIOTT T.S.J. - Birmingham, UK
ESPOSITO S. - Salerno, Italy
FANOS V. - Cagliari, Italy
FIETTA A.M. - Pavia, Italy
FIGURA N. - Siena, Italy
FIRSOV A.A. - Moscow, Russia
FRASCHINI F. - Milano, Italy
FRITSCHE T.R. - Marshfield, WI, USA
GEDDES A. - Solihull, UK
GHANNOUM M.A. - Cleveland, OH, USA
GIALDRONI G. - Pavia, Italy
GIAMARELLOU H. - Athens, Greece
GOULD I.M. - Aberdeen, UK
GRASSI C. - Pavia, Italy
HSUEH P.R. - Taipei, Taiwan
JONES R.N. - Iowa City, IA, USA
KRCMÉRY Jr.V. - Bratislava, Slovak Republic
LAZZARINI L. - Vicenza, Italy
LI R.C. - Palo Alto, CA, USA
LING J.M. - Shatin, Hong Kong
MACGOWAN A. - Bristol, UK
MARCHESE A. - Genova, Italy
MEMISH Z.A. - Riyadh, Saudi Arabia
MENICHETTI F. - Pisa, Italy
MORACE G. - Milano, Italy
NABER K.G. - Straubing, Germany
NICOLETTI G. - Catania, Italy
NORD C.E. - Huddinge, Sweden
OLIVIERI S. - Catania, Italy
PAGANO L. - Roma, Italy
PAPPAS G. - Ioannina, Greece
PARADISI F. - Firenze, Italy
PATERSON D.L. - Brisbane, Australia
PATTERSON T.F. - San Antonio, TX, USA
PICCININO F. - Napoli, Italy
PITOUT J.D.D. - Calgary, Canada
PRINCIPI N. - Milano, Italy
RIESBECK K. - Malmo, Sweden
ROMANI L. - Perugia, Italy
ROSSI F. - Napoli, Italy
ROSSOLINI G.M. - Siena, Italy
RUBINSTEIN E. - Winnipeg, Canada
SABIN C. - London, UK
SADER H.S. - North Liberty, IA, USA
SCAGLIONE F. - Milano, Italy
SCALISE G. - Ancona, Italy
SHIBL A.M. - Riyadh, Saudi Arabia
SIU L.K. - Zhunan Town, Taiwan
SORIANO F. - Madrid, Spain
STEFANI S. - Catania, Italy
TALIANI G. - Roma, Italy
TSAKRIS A. - Athens, Greece
VARALDO P.E. - Ancona, Italy
VENDITTI M. - Roma, Italy
VIALE P. - Bologna, Italy
VISCOLI C. - Genova, Italy
VIVIANI M.A. - Milano, Italy
WATANABE N. - Tsukuba, Japan
Advisory Board: Anticancer and Immunomodulating Agents
BAJETTA E. - Milano, Italy
BANERJEE D. - New Brunswick, NJ, USA
BERTINO J.R. - New Brunswick, NJ, USA
BIANCO A.R. - Napoli, Italy
BOCCARDO F. - Genova, Italy
BONMASSAR E. - Roma, Italy
BOSI A. - Firenze, Italy
BURGER A.M. - Detroit, MI, USA
CARRATO A. - Alicante, Spain
CHATELUT E. - Toulouse, France
D’ALESSANDRO N.- Palermo, Italy
DANESI R. – Pisa, Italy
D’INCALCI M. - Milano, Italy
ERNSTOFF M.S. - Lebanon, NH, USA
GEBBIA N. – Palermo, Italy
GESCHER A.J. – Leicester, UK
GIAVAZZI R. - Milano, Italy
GUICHARD S. - Edinburgh, UK
JODRELL D. – Edinburgh, UK
KAMEN B.A. - New Brunswick, NJ, USA
KÖHNE C-H. – Dresden, Germany
LABIANCA R. – Bergamo, Italy
LELLI G. - Ferrara, Italy
LONGLEY D.B. - Belfast, UK
MANTOVANI G. - Cagliari, Italy
MONTI E. - Busto Arsizio, Italy
MUGGIA F. - New York, NY, USA
NICOLIN A. - Milano, Italy
PETERS G.J. – Amsterdam, The Netherlands
PUJOL J.L. - Montpellier, France
RICCARDI C. – Perugia, Italy
ROBERT J. – Bordeaux, France
ROSELL R. - Barcelona, Spain
SAIJO N. – Tokyo, Japan
SAUSVILLE E.A – Baltimore, MD, USA
SAVA G. - Trieste, Italy
SCAGLIOTTI G. - Torino, Italy
SCAMBIA G. - Roma, Italy
SCHELLENS J.H.M. – Amsterdam, NL
SCHORNAGEL J. - Amsterdam, NL
TOFFOLI G.- Aviano, Italy
TORTORA G. - Napoli, Italy
VAN CUTSEM E. – Leuven, Belgium
VlANO I. - Novara, Italy
WILS J. – Roermond, The Netherlands
WORKMAN P. – Sutton, UK
ZAFFARONI N. - Milano, Italy
| 
